In a 2012 Congressional testimony, Dr. Fauci argued that US health agencies should pursue "dual use" (gain-of-function) research, despite the risks it poses.
In a 2012 Congressional testimony, Dr. Fauci argued that US health agencies should pursue "dual use" (gain-of-function) research, despite the risks it poses.